Literature DB >> 12895460

Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.

Xie Junxia1, Jiang Hong, Chen Wenfang, QianZhong Ming.   

Abstract

The effects of intranigral iron injection on dopamine (DA) release and content in the caudate putamen (CPu) and their relationship to DA-related behavioral response were investigated in rats. Different concentrations of FeCl(3) (10, 20, and 40 microg) and saline were injected separately into the left substantia nigra. In some experiments, rats were pretreated with desferrioxamine or saline before iron injection. After 3 weeks, changes in behavioral response, DA release, and DA content in the CPu were determined. In all iron injection groups (10, 20, and 40 microg), DA content in the lesioned side of the brain was significantly decreased, showing a significant linear correlation (R(2) = 0.981, P = 0.01), and DA turnover ratio significantly increased (both P = 0.01, 0.01 and 0.001 vs unlesioned sides, respectively). However, injection dosages of 10 or 20 microg of iron did not lead to significant changes in DA release in the CPu or in behavioral response. At the 40-microg dosage, it was found that DA release in the lesioned side and rearing activity both were significantly reduced (all P = 0.01 vs unlesioned side or control) and apomorphine-induced rotation was observed. Pretreatment with desferrioxamine significantly inhibited the effect of iron on DA release and content. These results demonstrate that iron injection can damage dopaminergic neurons and suggest that DA release, rather than DA content, in the CPu is associated with DA-related behavioral changes in this PD model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895460     DOI: 10.1016/s0014-4886(03)00123-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

Review 1.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

2.  Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells.

Authors:  Wen-Jing Li; Hong Jiang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

3.  Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.

Authors:  Juanjuan Dong; Ning Song; Junxia Xie; Hong Jiang
Journal:  J Mol Neurosci       Date:  2008-12-04       Impact factor: 3.444

4.  Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.

Authors:  Limin Shi; Xiling Bian; Zhiqiang Qu; Zegang Ma; Yu Zhou; KeWei Wang; Hong Jiang; Junxia Xie
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  CX3CL1/CX3CR1-mediated microglia activation plays a detrimental role in ischemic mice brain via p38MAPK/PKC pathway.

Authors:  Yong Liu; Xiao-Mei Wu; Qian-Qian Luo; Suna Huang; Qing-Wu Qian Yang; Fa-Xiang Wang; Ya Ke; Zhong-Ming Qian
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

6.  Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system.

Authors:  Jun Wang; Hong Jiang; Jun-Xia Xie
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

7.  Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells.

Authors:  Qing He; Ning Song; Huamin Xu; Rong Wang; Junxia Xie; Hong Jiang
Journal:  J Neural Transm (Vienna)       Date:  2010-08-06       Impact factor: 3.575

Review 8.  Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.

Authors:  Wei-na Cong; Erin Golden; Nick Pantaleo; Caitlin M White; Stuart Maudsley; Bronwen Martin
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 9.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

10.  Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro.

Authors:  Xixun Du; Huamin Xu; Limin Shi; Zhifeng Jiang; Ning Song; Hong Jiang; Junxia Xie
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.